• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质-死亡关联的反向流行病学研究:一项终末期肾病患者队列研究。

Reverse epidemiology of lipid-death associations in a cohort of end-stage renal disease patients.

机构信息

School of Education, Baylor University, Waco, TX, USA.

出版信息

Nephron Clin Pract. 2011;119(3):c214-9. doi: 10.1159/000329509. Epub 2011 Aug 11.

DOI:10.1159/000329509
PMID:21832847
Abstract

BACKGROUND AND AIMS

Cardiovascular disease is the leading cause of death among end-stage renal disease (ESRD) patients with hypercholesterolemia as a major cause. A few studies have demonstrated counter-intuitive findings known as reverse epidemiology where normal levels of cholesterol are associated with higher levels of mortality. The purpose of this study was to determine if there are reverse epidemiological associations between lipid risk factors and mortality in ESRD patients.

METHODS

ESRD (n = 438) patients were recruited from 4 outpatient dialysis units. Patients were tracked for 36 months until study completion or death with mortality status as the outcome measure.

RESULTS

Analysis of covariance revealed significant differences at posttest and reverse epidemiological effects for total cholesterol (p = 0.0001), low-density lipoprotein cholesterol (LDL) (p = 0.023), LDL particle number (p = 0.0001), LDL size (p = 0.009), triglycerides (p = 0.0001), and very low-density lipoprotein cholesterol (p = 0.036). A step-wise linear regression revealed weak, but significant predictors of mortality with total cholesterol (β = 0.263, p = 0.017) and LDL (β = -0.177, p = 0.045). A Cox death hazard ratio revealed LDL size as a significant predictor of mortality in this study.

CONCLUSIONS

Our study discovered reverse epidemiology in a number of lipid variables. Additionally regression revealed that LDL and total cholesterol were predictors of mortality with lower levels being more predictive of death.

摘要

背景与目的

心血管疾病是伴有高胆固醇血症的终末期肾病(ESRD)患者的主要死亡原因。一些研究表明,胆固醇水平正常与死亡率升高之间存在反常的关联,这种现象被称为反向流行病学。本研究旨在确定 ESRD 患者的血脂风险因素与死亡率之间是否存在反向流行病学关联。

方法

从 4 个门诊透析单位招募 ESRD(n = 438)患者。以死亡率为结局指标,对患者进行为期 36 个月的跟踪,直至研究完成或死亡。

结果

协方差分析显示,总胆固醇(p = 0.0001)、低密度脂蛋白胆固醇(LDL)(p = 0.023)、LDL 颗粒数(p = 0.0001)、LDL 大小(p = 0.009)、甘油三酯(p = 0.0001)和极低密度脂蛋白胆固醇(p = 0.036)在测试后存在显著差异,并且存在反向流行病学效应。逐步线性回归显示,总胆固醇(β = 0.263,p = 0.017)和 LDL(β = -0.177,p = 0.045)是死亡率的弱但有统计学意义的预测因子。Cox 死亡风险比显示 LDL 大小是本研究中死亡率的一个显著预测因子。

结论

我们的研究在多个血脂变量中发现了反向流行病学。此外,回归分析显示 LDL 和总胆固醇是死亡率的预测因子,较低水平的 LDL 和总胆固醇更能预测死亡。

相似文献

1
Reverse epidemiology of lipid-death associations in a cohort of end-stage renal disease patients.脂质-死亡关联的反向流行病学研究:一项终末期肾病患者队列研究。
Nephron Clin Pract. 2011;119(3):c214-9. doi: 10.1159/000329509. Epub 2011 Aug 11.
2
Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.低密度脂蛋白胆固醇:与血液透析患者死亡率及住院率的关联
Blood Purif. 2005;23(2):134-40. doi: 10.1159/000083529. Epub 2005 Jan 21.
3
Malnutrition, inflammation, and lipids in a cohort of dialysis patients.透析患者队列中的营养不良、炎症和脂质。
Postgrad Med. 2010 May;122(3):196-202. doi: 10.3810/pgm.2010.05.2158.
4
The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.使用别嘌醇降低尿酸水平对终末期肾病患者代谢综合征标志物的影响:一项初步研究。
Anadolu Kardiyol Derg. 2009 Oct;9(5):385-9.
5
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.非高密度脂蛋白胆固醇(non-HDL-C)作为终末期肾病患者心血管死亡的预测指标。
Kidney Int Suppl. 2003 May(84):S117-20. doi: 10.1046/j.1523-1755.63.s84.30.x.
6
[Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].[洛伐他汀和普罗布考对高胆固醇血症患者脂蛋白组分的影响。一项巴西多中心研究]
Arq Bras Cardiol. 1991 Sep;57(3):253-61.
7
Plasma triglyceride level and mortality from coronary heart disease.血浆甘油三酯水平与冠心病死亡率
N Engl J Med. 1993 Apr 29;328(17):1220-5. doi: 10.1056/NEJM199304293281702.
8
Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.阿托伐他汀对长期透析患者低密度脂蛋白胆固醇表型及C反应蛋白水平的影响
Pharmacotherapy. 2005 Mar;25(3):335-44. doi: 10.1592/phco.25.3.335.61599.
9
Significance of alterations in plasma lipid profile levels in breast cancer.乳腺癌患者血浆脂质谱水平改变的意义
Integr Cancer Ther. 2008 Mar;7(1):33-41. doi: 10.1177/1534735407313883.
10
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.依折麦布/辛伐他汀对原发性高胆固醇血症患者脂蛋白亚组分的影响:使用两种市售技术对存档样本进行的探索性分析。
Clin Ther. 2007 Nov;29(11):2419-32. doi: 10.1016/j.clinthera.2007.10.004.

引用本文的文献

1
The predictive value of TG/HDL and TC/HDL for risk of mortality and cardiovascular events in incident peritoneal dialysis patients.甘油三酯/高密度脂蛋白和总胆固醇/高密度脂蛋白对新发腹膜透析患者死亡风险和心血管事件的预测价值。
Clin Kidney J. 2025 May 27;18(6):sfaf165. doi: 10.1093/ckj/sfaf165. eCollection 2025 Jun.
2
Kidney function trajectories, associated factors, and outcomes in multiethnic Asian patients with type 2 diabetes.多民族亚洲 2 型糖尿病患者的肾功能轨迹、相关因素和结局。
J Diabetes. 2024 Sep;16(9):e13523. doi: 10.1111/1753-0407.13523. Epub 2024 Jan 2.
3
Hyperlipidemia and mortality associated with diabetes mellitus co-existence in Chinese peritoneal dialysis patients.
中国腹膜透析患者中糖尿病合并高脂血症与死亡率的关系。
Lipids Health Dis. 2020 Nov 7;19(1):234. doi: 10.1186/s12944-020-01405-5.
4
The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值升高与腹膜透析患者死亡率的预测研究。
Lipids Health Dis. 2020 Mar 21;19(1):51. doi: 10.1186/s12944-020-01240-8.
5
The effect of chronic kidney disease on lipid metabolism.慢性肾脏病对脂质代谢的影响。
Int Urol Nephrol. 2019 Feb;51(2):265-277. doi: 10.1007/s11255-018-2047-y. Epub 2018 Dec 5.
6
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations.糖尿病和非糖尿病人群肾功能的循环代谢生物标志物。
Sci Rep. 2018 Oct 15;8(1):15249. doi: 10.1038/s41598-018-33507-7.
7
Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.低密度脂蛋白胆固醇与肺动脉高压患者的生存。
Sci Rep. 2017 Feb 15;7:41650. doi: 10.1038/srep41650.
8
Contrast nephropathy: Risk factors and the role of beta blockers.对比剂肾病:危险因素及β受体阻滞剂的作用
Anatol J Cardiol. 2015 Mar;15(3):241. doi: 10.5152/akd.2015.14769.
9
Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis.透析开始后,血清炎症标志物的变化与载脂蛋白A1的变化相关,但与载脂蛋白B的变化无关。
Nephrol Dial Transplant. 2014 Feb;29(2):430-7. doi: 10.1093/ndt/gft370. Epub 2013 Sep 5.
10
Pre-ESRD changes in body weight and survival in nursing home residents starting dialysis.开始透析的养老院居民终末期肾病前的体重变化与生存情况。
Clin J Am Soc Nephrol. 2013 Oct;8(10):1734-40. doi: 10.2215/CJN.01410213. Epub 2013 Sep 5.